Tamoxifen in breast cancer survivors with COVID 19: stop or go?

Thumbnail

Göster/Aç

Erişim

info:eu-repo/semantics/closedAccess

Tarih

2021

Yazar

Karaçin, Cengiz
Karaçin, Pınar
Ergün, Yakup

Üst veri

Tüm öğe kaydını göster

Künye

Karacin, C., Karacin, P., & Ergun, Y. (2021). Tamoxifen in breast cancer survivors with COVID 19: stop or go?. Medical oncology (Northwood, London, England), 38(4), 42. https://doi.org/10.1007/s12032-021-01492-z

Özet

The COVID 19 pandemic threatens human health in many ways. Although vaccines that have completed phase 3 trials are being used today, it is estimated that the risk of infection will continue for a while

Kaynak

Medical Oncology

Cilt

38

Sayı

4

Bağlantı

https://doi.org/10.1007/s12032-021-01492-z
https://hdl.handle.net/11436/6279

Koleksiyonlar